GPs are being encouraged to regularly screen patients with MS for dyslipidaemia in a new guide that warns the comorbidity contributes to progression of disability.

The evidence-based guide for health professionals was released by MS Research Australia and covers comorbidities, gut health, diet, supplements, sun exposure and exercise.

Called Modifiable Lifestyle Factors and MS, it cites recent evidence suggesting adverse lipid profiles in patients are associated with worse disability outcomes and inflammatory lesions.

“Health professionals are encouraged to proactively monitor lipid profiles of people with MS and consider pharmaceutical interventions, such as the use of statins where appropriate,” it states, adding the agents are well tolerated and safe in MS.